Imperial Ginseng Products  

(Public, CVE:IGP)   Watch this stock  
Find more results for IGP
0.000 (0.00%)
Oct 1 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 0.98
Open     -
Vol / Avg. 0.00/1,196.00
Mkt cap 4.25M
P/E 0.18
Div/yield     -
EPS 3.26
Shares 7.21M
Beta 1.17
Inst. own     -

Key stats and ratios

Q2 (Jun '15) 2015
Net profit margin -5.52% 55.29%
Operating margin 82.33% 74.76%
EBITD margin - 6.70%
Return on average assets -1.74% 18.91%
Return on average equity 369.78% 129.24%
CDP Score - -


Suite 310 - 650 West Georgia Street PO Box 11549
+1-604-6898863 (Phone)
+1-604-6898892 (Fax)

Website links


Imperial Ginseng Products Ltd. is a Canada-based Company that cultivates and processes ginseng in Ontario. The Company runs its core business, cultivation of North American ginseng through its wholly owned subsidiary Canadian Imperial Ginseng Ontario Ltd. The Company owns a processing facility in Otterville, Ontario and its farm operations are primarily in Ontario. Ginseng is an herbaceous perennial herb, which is used as a folk medicine and general tonic in Asia and is a foundation of Chinese herbal medicine. Ginseng is frequently used as a potent preventative rather than a curative. It has demonstrated therapeutic benefits for a wide number of ailments and conditions.

Officers and directors

Hugh R. Cartwright Co-Chairman of the Board, President
Age: 52
Stephen P. McCoach Co-Chairman of the Board, Chief Executive Officer, Secretary
Amelia Yeo Chief Financial Officer
Age: 50
Maurice Levesque Executive Vice President, Director
Age: 56
James S. Chang Director
Age: 64
Joseph A. Rogers Independent Director
Age: 80